查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529575

药物基因学测试市场：按技术、按应用、按最终用户、按地区

Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction, Sequencing, Microarray Analysis, and Other Technologies), By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球药物基因测试市场规模为131.1亿美元，预计2031年将达241亿美元，2024年至2031年复合年增长率为9.1%。

报告范围 报告详情
基准年 2023年 2024年市场规模 131.1亿美元
实际资料 2019-2023 预测期 2024-2031
2024-2031 年预测期复合年增长率 9.10% 2031 年金额预测 241亿美元
图：2024 年各地区药物基因检测市场占有率(%)
药物基因检测市场-IMG1

药物基因测试是一种检查个体遗传变异并检查其代谢和对药物反应的能力的技术。此测试有助于根据个人的遗传倾向确定药物的安全性和有效性。该测试在精准医疗和个人化医疗实践中发挥着至关重要的作用，精准医疗和个人化医疗根据个人的基因谱量身定制治疗方法、剂量和持续时间。随着基因组技术的进步和全基因组序列测定成本的降低，遗传药物测试市场在全球范围内快速成长。

市场动态：

全球药物基因学检测市场的推动因素包括需要长期药物治疗的慢性病盛行率上升、个人化医疗需求不断增长、基因组技术成本下降以及直接面向消费者的基因检测套组的采用不断增加。然而，缺乏支持遗传药理学测试的临床证据、医生不愿广泛使用以及报销问题给市场成长带来了挑战。商业机会包括扩大药物遗传学研究活动以发现新的生物标誌物，与製药和诊断公司合作开发伴同性诊断，以及扩展到亚洲和拉丁美洲的新兴国家。

本研究的主要特点

  • 该报告对全球药物遗传学测试市场进行了详细分析，以2023年为基准年估计了预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球药物基因测试市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球药物基因测试市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于全球药物基因测试市场分析的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球药物基因测试市场－冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球药物基因测试市场（按技术），2019-2031（十亿美元）

  • 介绍
  • 聚合酵素链锁反应(PCR)
  • 定序
  • 微阵列分析
  • 其他的

第六章 2019-2031 年全球药物基因测试市场（按应用）（十亿美元）

  • 介绍
  • 心臟病学
  • 胃肠病学
  • 内分泌学
  • 免疫学和超敏反应
  • 妇科
  • 肿瘤学
  • 神经病学
  • 其他的

第七章 全球药物基因测试市场，依最终用户划分，2019-2031 年（十亿美元）

  • 介绍
  • 医院/诊所
  • 学术研究所
  • 生物製药公司
  • 其他的

第八章全球药物基因测试市场，按地区，2019-2031（十亿美元）

  • 介绍
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争格局

  • 公司简介
    • Abbott Laboratories
    • Admera Health
    • Agena Bioscience
    • BiogeniQ
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Gene by Gene, Ltd.
    • Genomic Health
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings（LabCorp）
    • Myriad Genetics, Inc.
    • OneOme, LLC
    • OPKO Health, Inc.
    • Quest Diagnostics Incorporated
    • Roche Molecular Diagnostics
    • Sonic Healthcare
    • Thermo Fisher Scientific Inc.
    • 23andMe, Inc.

第10章分析师建议

  • 上升和下降
  • 综合机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI7089

The global pharmacogenetic testing market is estimated to be valued at USD 13.11 Bn in 2024 and is expected to reach USD 24.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 13.11 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 9.10% 2031 Value Projection: US$ 24.10 Bn
Figure. Pharmacogenetic Testing Market Share (%), By Region 2024
Pharmacogenetic Testing Market - IMG1

Pharmacogenetic testing is a technique that examines genetic variations of individuals to check their ability to metabolize and respond to drugs. It helps determine the safety and efficacy of medications for an individual based on their genetic makeup. This testing plays a pivotal role in practicing precision or personalized medicine wherein the treatment, its dosage, and duration are customized based on an individual's genetic profile. With the advancement of genomic technologies and declining costs of whole genome sequencing, the market for pharmacogenetic testing is growing rapidly worldwide.

Market Dynamics:

The global pharmacogenetic testing market is driven by rising incidence of chronic diseases requiring long term medication, growing demand for personalized healthcare, declining costs of genomic technologies, and increasing adoption of direct-to-consumer genetic testing kits. However, lack of clinical evidence supporting pharmacogenetic testing, reluctance among physicians for widespread adoption, and reimbursement issues pose challenges to the market growth. Opportunities include growing research activities in pharmacogenomics to discover new biomarkers, partnerships between pharmaceutical companies and diagnostic firms to develop companion diagnostics, and expansion into emerging Asian and Latin American countries.

Key Features of the Study:

  • This report provides in-depth analysis of the global pharmacogenetic testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmacogenetic testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Illumina, Inc, Abbott Laboratories, F. Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmacogenetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenetic testing market

Detailed Segmentation-

  • By Technology
    • Polymerase Chain Reaction (PCR)
    • Sequencing
    • Microarray Analysis
    • Other Technologies
  • By Application
    • Cardiology
    • Gastroenterology
    • Endocrinology
    • Immunology & Hypersensitivity
    • Gynecology
    • Oncology
    • Neurology
    • Others
  • By End User
    • Hospitals & Clinics
    • Academic & Research Institutes
    • Biopharmaceutical Companies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Admera Health
    • Agena Bioscience
    • BiogeniQ
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Gene by Gene, Ltd.
    • Genomic Health
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • Myriad Genetics, Inc.
    • OneOme, LLC
    • OPKO Health, Inc.
    • Quest Diagnostics Incorporated
    • Roche Molecular Diagnostics
    • Sonic Healthcare
    • Thermo Fisher Scientific Inc.
    • 23andMe, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Pharmacogenetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Pharmacogenetic Testing Market, By Technology, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Polymerase Chain Reaction (PCR)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Microarray Analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Other Technologies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmacogenetic Testing Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cardiology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Gastroenterology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Endocrinology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunology & Hypersensitivity
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Gynecology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neurology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmacogenetic Testing Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic & Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biopharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmacogenetic Testing Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Admera Health
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agena Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BiogeniQ
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cepheid
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Gene by Gene, Ltd.
    • Genomic Health
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • Myriad Genetics, Inc.
    • OneOme, LLC
    • OPKO Health, Inc.
    • Quest Diagnostics Incorporated
    • Roche Molecular Diagnostics
    • Sonic Healthcare
    • Thermo Fisher Scientific Inc.
    • 23andMe, Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Reference and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact